HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 7,261-7,272 of 27,277
Drug study icon
CompletedNCT00119756

Paliperidone palmitate injection safety in the shoulder or buttock

About this title

A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With Schizophrenia

Read the official source — NCT00119756
What is this study about?

This study evaluated the safety of paliperidone palmitate for people with schizophrenia.

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaMedication studyAges 18+
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug study icon
CompletedNCT00845026

A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients

What is this study about?

Researchers compared LY2140023, aripiprazole, olanzapine and risperidone, tracking side effects to assess long-term safety and tolerability in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Escondido
SchizophreniaMedication studyAges 18–65
Countries
United States, Germany, Mexico, + 1 other
Sponsor
Denovo Biopharma LLC
Drug study icon
CompletedNCT05233085

A Safety Study of AZD4041 in Healthy Participants

Official study title

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of AZD4041 in Healthy Adult Subjects

This study has finished and is no longer accepting participants.

In Laval
AddictionMedication studyAges 18–55
Countries
Canada
Sponsor
AstraZeneca
Drug study icon
CompletedNCT02476058

Safety study of JNJ-42847922 in depression

What is this study about?

Researchers compared JNJ-42847922, Diphenhydramine and placebo, tracking side effects to assess safety and tolerability in people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Aalst
DepressionMedication studyAges 18–64
Countries
Belgium, Germany, Netherlands
Sponsor
Janssen-Cilag International NV
Drug study icon
CompletedNCT03565068

Safety study of MK-8189 in schizophrenia

Official study title

A Multiple-dose Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and QTc Effect of MK-8189 in Participants With Schizophrenia and Healthy Participants.

This study has finished and is no longer accepting participants.

In Glendale
SchizophreniaMedication studyAges 18–60
Countries
United States
Sponsor
Merck Sharp & Dohme LLC
Drug study icon
CompletedNCT01051531

A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to people with Schizophrenia

What is this study about?

Researchers studied Paliperidone palmitate to find out how it affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Dandenong
SchizophreniaMedication studyAges 18–50
Countries
Australia, New Zealand, China, + 5 others
Sponsor
Janssen Research & Development, LLC
Drug study icon
CompletedNCT05721235

A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD

Official study title

A Multicenter, Dose-Optimized, Open-Label, Safety/Tolerability and Pharmacokinetic Study With Azstarys® in Children 4 and 5 Years of Age With Attention-Deficit/Hyperactivity Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
ADHDMedication studyAges 4–5
Countries
United States
Sponsor
Corium, Inc.
Behavioral study icon
CompletedNCT06026306

A Scalable Psychological Intervention for Earthquake Survivors in Türkiye

Official study title

A Pilot Randomized Controlled Trial of a Scalable Psychological Intervention for Enhancing Mental Health Outcomes Among Earthquake Survivors in Türkiye

This study has finished and is no longer accepting participants.

In Istanbul
DepressionBehavioural studyAges 18+
Countries
Türkiye
Sponsor
Koç University
Behavioral study icon
CompletedNCT04980326

A Scalable Psychological Intervention to Reduce Psychological Distress Among Healthcare Workers

Official study title

A Scalable Low-intensity Psychological Intervention to Reduce Psychological Distress Among Healthcare Workers Involved in the First COVID-19 Outbreak in Spain: a Randomized Trial

This study has finished and is no longer accepting participants.

Multiple locations, including Sant Boi de Llobregat
Anxiety, DepressionBehavioural studyAges 18+
Countries
Spain
Sponsor
Instituto de Investigación Hospital Universitario La Paz

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.